ABBV
AbbVie Inc. Common Stock (ABBV)
$96
About AbbVie Inc. Common Stock (ABBV)
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Details
Daily high
$266.34
Daily low
$262.44
Price at open
--
52 Week High
$267.47
52 Week Low
$190.75
Market cap
466.4B
Dividend yield
2.59%
Volume
303
Avg. volume
4.3M
P/E ratio
74.63
AbbVie Inc. Common Stock News
Details
Daily high
$266.34
Daily low
$262.44
Price at open
--
52 Week High
$267.47
52 Week Low
$190.75
Market cap
466.4B
Dividend yield
2.59%
Volume
303
Avg. volume
4.3M
P/E ratio
74.63